Niki BioSolutions NIKI
NASDAQ NIKI
$4.60 -0.26 (-5.35%)
At close: Oct 2, 2026 · 4:00 PM EDT

Niki BioSolutions (NIKI) Non Operating Investment Income (2017)

Updated

Niki BioSolutions (NIKI) reported Non Operating Investment Income of -$1 million for FY2024, compared with -$6.43 million in FY2023.

Analysis

Niki BioSolutions (NIKI) Non Operating Investment Income (2017) Analysis & Trends

Dating back to FY2017, Niki BioSolutions' Non Operating Investment Income record includes 6 years.

  • The FY2024 figure ranks as the highest annual Non Operating Investment Income since FY2021.
  • According to Business Quant data, Non Operating Investment Income came in at -$6.43 million in FY2023, -$6.11 million in FY2022 and -$3,638 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Niki BioSolutions 2.51 Mn 2.51 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 -367,782.00
API Access

Niki BioSolutions Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=NIKI&period=max&api_key=YOUR_API_KEY